vimarsana.com

Joel Beatty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

INmune Bio, Inc (NASDAQ:INMB) Q1 2024 Earnings Call Transcript

INmune Bio, Inc (NASDAQ:INMB) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMark lowdellInmune bioJason mccarthyTom shraderJoel beattyDavid mossMaxim groupInmune bio incCall transcript mayBio first quarterChief scientific officerSafe harborPrivate securities litigation reform actHighest annual

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesKimberly manhardJason butlerJoel beattyDavid hoangBrendan teehanElaine kimParag meswaniCarbidopa levodopa trxsKimberly manhartSteve davisTessa romeroJose loraAl kildaniGregory renzaMark schneyer

Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript

AXSM earnings call for the period ending March 31, 2024.

Darren oplandHerriot tabuteauMarc goodman leerinkJason gerberryNick pizzieMark jacobsonDavid amsellem piper sandlerRam selvarajuVikram purohitJoel beattyCharles duncanGraig suvannavejhYatin sunejaVikram purohit morgan stanleyMarc goodmanMyles minter

Geron (GERN) Q1 2024 Earnings Call Transcript

GERN earnings call for the period ending March 31, 2024.

Stephen willeyJohn scarlettTara bancroftAaron feingoldAndrew grethleinKalpit patelGil blumFaye fellerMichelle robertsonGil blum needhamKalpit patelb rileyKarin johnsonGraig suvannavejh goldman sachsJoel beattyBristol myers squibbData monitoring committee

7 Analysts Assess Alkermes: What You Need To Know

Throughout the last three months, 7 analysts have evaluated Alkermes (NASDAQ:ALKS), offering a diverse set of opinions from bullish to bearish. Th.

Ashwani vermaAkash tewariDavid amsellemPiper sandlerDouglas tsaoJoel beattyAnalyst firmHc wainwright coHealth careAnalyst ratingsCapitalization analysis

vimarsana © 2020. All Rights Reserved.